Citi Pharma and CCL Pharma execute agreement to manufacture Formulation Products

MG News | July 14, 2021 at 03:22 PM GMT+05:00

0:00

July 14, 2021 (MLN): Citi Pharma Limited (CPHL) and CCL Pharma (Pvt) Limited have executed an agreement to manufacture Formulation Products on their behalf

In a notification to PSX, CPHL informed that this will lead to enhance capacity utilization on the Company’s Formulation segment. Furthermore, this will lead to the addition in Company’s profitability and net margins over the next 2 to 3 years.

Copyright Mettis Link News

Related News

PSX Closing Bell: You Are the Reason

TOMCL secures $5.2m Saudi export deal

Hinopak Motors swings back to profit in 1HFY26

Name	Price/Vol	%Chg/NChg
KSE100	163,188.53 234.70M	0.93% 1496.04
ALLSHR	98,429.46 635.18M	0.52% 510.22
KSE30	49,735.93 108.72M	1.34% 655.86
KMI30	232,829.71 86.13M	1.15% 2645.61
KMIALLSHR	63,800.86 233.22M	0.53% 337.97
BKTi	44,493.13 46.30M	1.35% 594.19
OGTi	31,741.52 12.64M	1.02% 319.85

Symbol	Bid/Ask	High/Low

Name	Last	High/Low	Chg/%Chg
BITCOIN FUTURES	86,915.00	88,210.00 86,665.00	-505.00 -0.58%
BRENT CRUDE	62.46	62.86 62.11	-0.02 -0.03%
RICHARDS BAY COAL MONTHLY	85.00	0.00 0.00	0.10 0.12%
ROTTERDAM COAL MONTHLY	96.00	96.00 96.00	0.00 0.00%
USD RBD PALM OLEIN	1,016.00	1,016.00 1,016.00	0.00 0.00%
CRUDE OIL - WTI	57.98	58.30 57.66	0.03 0.05%
SUGAR #11 WORLD	14.98	15.01 14.86	0.07 0.47%